Newsletter 2020 – Issue 2; Business Update – Hamlet Pharma receives EU grant for €2.2M Last month, members of the Hamlet Pharma Executive Team travelled…
Read More
Newsletter 2020 – Issue 1; Bladder Cancer “Bladder cancer (BC) has the highest lifetime treatment costs per patient (pp) of all cancers, followed by colorectal-,…
Press Release, Lund February 5, 2020 Alpha1H shows significant promise as a new and effective cancer drug with low toxicity in a clinical bladder cancer…
Pressmeddelande, Lund 3 februari, 2020 Hamlet Pharma tillförs 12,95 miljoner SEK genom inlösen av teckningsoptioner utfärdade i samband med den riktade emissionen från den 1…